A Study of Gemcitabine-Cisplatin Chemotherapy Plus Necitumumab in the First-Line Treatment of Participants With Squamous Lung Cancer
Clinical trial NCT01788566 · COMPLETED
Trial details
- NCT number
- NCT01788566
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-01
- Primary completion
- 2014-08-01
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.